Identifying New Risk Factors for Comorbidities in the Elderly

Area of Science:

• Geriatric Medicine
• Biomarker Discovery
• Predictive Modeling

Background:

• Investigating high-density lipoprotein cholesterol (HDL-C) and fasting blood glucose (FBG) as novel biomarkers for geriatric comorbidities.
• Utilizing data from 316 patients with geriatric comorbidities.
• Assessing the impact of HDL-C and FBG on comorbidity severity and the utility of a nomogram prediction model.

Purpose of the Study:

• Evaluate HDL-C and FBG as biomarkers for geriatric comorbidity risk.
• Assess the predictive accuracy and clinical utility of a nomogram model for managing elderly comorbidities.
• Explore the clinical value of the nomogram model in an aging population.

Main Methods:

• Cross-sectional study design.
• Statistical analyses including logistic regression, Lasso regression, and calibration analysis.
• Internal and external validation of the nomogram prediction model using decision curve analysis.

Main Results:

• HDL-C negatively associated with comorbidity risk (OR = 0.387, p < 0.05).
• FBG positively associated with comorbidity risk (OR = 1.050, p < 0.05).
• Nomogram model demonstrated high predictive accuracy and excellent calibration, confirming clinical utility.

Conclusions:

• HDL-C and FBG are critical biomarkers for assessing comorbidity risk in the elderly.
• The nomogram prediction model shows potential for risk prediction and management of elderly comorbidities.
• Findings support the use of HDL-C and FBG in clinical practice for predicting and intervening in elderly comorbidities.